Bristol Myers Squibb (BMY) cash: $10.2B
Bristol Myers Squibb held $10.2B in cash and cash equivalents on Dec 31, 2025, down 1.3% from $10.3B a year earlier.
From Bristol Myers Squibb's filings with the SEC · Read the filing · BMY stock page
Bristol Myers Squibb cash by year
#60 of 4,171 US companies by cash · See the full ranking
| Year ended | Cash | Change |
|---|---|---|
| Dec 31, 2025 | $10.2B | -1% |
| Dec 31, 2024 | $10.3B | -10% |
| Dec 31, 2023 | $11.5B | +26% |
| Dec 31, 2022 | $9.1B | -35% |
| Dec 31, 2021 | $14B | – |
Cash of similar companies
Companies in the same industry as Bristol Myers Squibb, by SEC industry code, with the closest cash. Each name opens the same page for that company.
| Company | Cash, latest year | Year ended |
|---|---|---|
| Johnson & Johnson | $19.7B | Dec 28, 2025 |
| Merck | $14.6B | Dec 31, 2025 |
| Bristol Myers Squibb | $10.2B | Dec 31, 2025 |
| Abbott Laboratories | $8.5B | Dec 31, 2025 |
| Eli Lilly | $7.3B | Dec 31, 2025 |
| AbbVie | $5.2B | Dec 31, 2025 |
| Vertex Pharmaceuticals Inc / Ma | $5.1B | Dec 31, 2025 |
Questions and answers
What is Bristol Myers Squibb's cash?
Bristol Myers Squibb held $10.2B in cash and cash equivalents on Dec 31, 2025, down 1.3% from $10.3B a year earlier.
Numbers as reported in Bristol Myers Squibb's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology